Inhalation of chrysotile asbestos induces rapid cellular proliferation in small pulmonary vessels of mice and rats. by McGavran, Patricia D. et al.
AmericanJournal ofPathology, Vol. 136, No. 3, March 1990
Copyright© American Association ofPathologists
Inhalation of Chrysotile Asbestos Induces Rapid
Cellular Proliferation in Small Pulmonary
Vessels of Mice and Rats
Patricia D. McGavran,* Lynne B. Moore,t
and Arnold R. Brodyt
From the Curriculum in Toxicology,* University ofNorth
Carolina at Chapel Hill, Chapel Hill, and the Laboratory of
Pulmonary Pathobiology,j National Institute of
Environmental Health Sciences, Research Triangle Park,
North Carolina
Asbestos inhalation in mice and rats causes a rapid
proliferative response in epithelial and interstitial
cells, followed by the development ofan interstitial
lesion at thefirst alveolar duct bifurcations where
fiber deposition andalveolar macrophage accumu-
lation occur. Here we report that endothelial and
smooth muscle cells ofarterioles and venules near
the bifurcations incorporated significantly in-
creased levels of-3H- TdR 19 to 72 hours after chryso-
tile exposure. As many as 28% of the vessels had
labeled cells 31 hours after exposure. No labeled
cells were observed in vesselsfrom sham-exposed or
iron-exposed controls. This proliferative response
resulted in a doubling of both the number of
smooth muscle cells and the thickness of the
smooth muscle cell layer, determined by ultrastruc-
tural morphometry I month after exposure. The
fact that a variety ofcell types incorporates 3-H- TdR
so rapidly after asbestos inhalation leads us to spec-
ulate that the response involves the release of
diffusible growthfactors. (AmJPathol 1990, 136:
695- 705)
Inhalation of chrysotile asbestos fibers causes progres-
sive interstitial fibrosis in both humans' and experimental
animals.1 We have developed a rodent model for study-
ing the basic mechanisms of asbestos-induced interstitial
lung disease.4 6 With this model, we have learned that
inhaled fibers are deposited initially at the bifurcations of
alveolar ducts and that alveolar and interstitial macro-
phages are attracted to these sites of deposition by a
complement-dependent mechanism.57'0 One of the ear-
liest sequelae of particle deposition is an increase in triti-
ated thymidine (3H-TdR) incorporation by a variety of cell
types in the bronchiolar-alveolar regions.6 These cells in-
clude nonciliated epithelial cells of the terminal bronchi-
oles, as well as type 11 epithelial and interstitial cells of the
alveolar duct bifurcations. The percentage of cells that
incorporates 3H-TdR 19 to 48 hours after a 5-hour asbes-
tos exposure is increased up to 18-fold over normal unex-
posed animals.6 These findings correlate with increases
in numbers of epithelial and interstitial cells shown by ul-
trastructural morphometry.5 Increases in 3H-TdR incorpo-
ration and cell numbers in asbestos-exposed rats were
found only in the regions of the bronchiolar-alveolar junc-
tions. Alveolar ducts distal to the first bifurcation and pa-
renchymal tissue in sections cut randomly throughout the
lung showed no measurable changes.56 Ultrastructural
morphometry demonstrated no change in the number or
volume of capillary endothelial cells at the bifurcations,5
but the responses of the cells of arterioles and venules
had not been studied in this model of interstitial lung dis-
ease.
In the paper presented here, we extend our observa-
tions on the pathogenesis of the earliest asbestos-in-
duced lung lesions and show that endothelial and smooth
muscle cells of small vessels of the bronchiolar-alveolar
regions exhibit dramatic increases in incorporation of 3H-
TdR. Normal endothelial cells lining blood vessels are
known to exhibit a remarkably low turnover rate, perhaps
best expressed in terms of years."1'14 Smooth muscle
cells in the medial walls of normal small vessels also ex-
hibit a very low proliferative rate, with less than 1% of the
cells in S phase of the cell cycle at any point in time.'1415
Although the proliferation of these cells is an important
part of embryonic tissue growth and wound repair,'1617 as
well as the pathologic processes of diabetic retinopathy,18
atherosclerosis,'9 and tumor growth,20 there is no evi-
dence that the cells of small pulmonary vessels respond
in any way after inhalation of a fibrogenic dust such as
asbestos.
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The striking increase in 3H-TdR incorporation reported
here may be significant because this proliferative re-
sponse resulted in increased numbers of smooth muscle
cells and concomitant thickening of the vessel walls.
These findings support the view that diffusible, perhaps
macrophage-derived, mitogenic factors are elaborated
very soon after the deposition of asbestos fibers at the
alveolar duct bifurcations and provide an anatomic basis
for ongoing in vitro studies designed to characterize the
factors at biochemical and molecular levels.
Methods
Asbestos Exposures
Male mice, strain B10.D2/nSn (The Jackson Laboratory,
Bar Harbor, ME), which were 8 weeks old, were exposed
in two separate experiments to an aerosol of chrysotile
asbestos (4 mg/m3 respirable mass) for 5 hours in open
cages as previously described.8'9 Control animals were
sham exposed to room air.
3H-thymidine (6.7 Ci/mmol; Amersham, Arlington
Heights, IL) was administered (2 ,uCi/g) to the animals in-
traperitoneally after recovery periods of 0, 19, 24, 31, and
48 hours, 8 days, and 1 month for the first exposure, 24,
48, and 72 hours for the second, and 24, 48, 72 hours,
and 1 month for the controls in both exposures after as-
bestos inhalation. Four hours after the administration of
3H-TdR, the animals were killed by intraperitoneal injection
of 25 mg/ml sodium pentobarbitol.
Tissue Preparation
Lungs from mice were fixed by vascular perfusion via the
pulmonary artery with a fixative of 1% glutaraldehyde and
1% paraformaldehyde in 0.1 M sodium cacodylate buffer
with 5 mmol CaCI2, at 23 cm H20 pressure for 5 minutes.
Whole lungs were removed from the animal and im-
mersed in fixative overnight. After overnight fixation, the
volume of fixed lungs was determined by water displace-
ment and a portion of lung tissue was taken for histologic
examination. After histologic verification that the animals
showed no evidence of chronic lung disease or infection,
slices of fixed tissue approximately 2 x 5 x 6 mm in size,
adjacent to the slices taken for histology, were taken from
the left lung, at right angles to each mainstem bronchus.
The slices were postfixed with 0.5% osmium tetroxide in
veronal acetate buffer, dehydrated with ethanol and pro-
pylene oxide, and embedded in soft epox 812 plastic
resin, which was then polymerized at 60 C for 15 hours.
The blocks of embedded tissue were softened on a
warming tray and slices approximately 0.5 mm thick were
cut parallel to the large tissue face with a razor blade. Ter-
minal bronchioles with their attached alveolar ducts and
alveolar duct bifurcations were randomly selected under
a dissecting microscope using a bright light reflected from
the surface of the cut block face, which clearly revealed
the orientation of the lung tissue. The selected bifurca-
tions were cut from the warmed plastic block and glued
on to a blank epoxy capsule with epoxy glue, as pre-
viously described by Warheit et al.8
Microscopic Analysis and Autoradiography
Thick sections (0.5 ,m) were cut with a diamond knife
on a MT5000 microtome (Dupont, Wilmington DE), wet
mounted on glass slides, and coated with a 1:1 dilution of
Ilford L4 emulsion and distilled water. The sections were
exposed in dessicated, light-tight boxes kept in total dark-
ness at 4 C for 3 weeks, developed in Kodak D-19, fixed
in Kodak fixer, washed for 45 minutes, and allowed to air
dry. Sections were stained with toluidine blue-azure 11.
Cell nuclei of all vessels in each section were counted
by light microscopy at 1OOX magnification. A nucleus with
six or more grains was considered labeled. Radiolabeled
endothelial and smooth muscle cell nuclei were counted
and expressed as a percentage of total cell nuclei (label-
ing index). Vessels were randomly selected because the
tissue was originally dissected to expose terminal bron-
chioles and first alveolar duct bifurcations and the vessels
were not a concern in selecting these tissues. The diame-
ter of vessels cut in cross section were measured from
photographs. The relationship between 3H-thymidine in-
corporation and the proximity of the vessel to the airway
was determined by comparing the labeling index in ves-
sels placed in three groups according to anatomical loca-
tion: 1) adjacent to the terminal bronchiole, 2) within 100
Am of the terminal bronchiole, and 3) peripheral to, or fur-
ther than 100 Mm from the terminal bronchiole. Examples
of vessels in the three groups are shown in Figure 1.
Additional tissues from 8-week-old male CD(SD)BR
rats (Charles River, Raleigh, NC) exposed for 5 hours to
asbestos (_10 mg/m3 respirable mass) or carbonyl iron
(30 mg/m3), and prepared for autoradiography as de-
scribed above, were available from earlier studies,6 and
vessel labeling was determined in these rat lungs 19, 24,
33, and 48 hours after exposure.
Morphometry
Morphometric measurements were carried out on vessels
in the bifurcation regions of asbestos and sham-exposed
mice 72 hours, 8 days, and 1 month after exposure. Thin
sections adjacent to thick sections taken for autoradiogra-
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Figure 1. Section oflung tissuefrom a mouse illustrating a ter-
minal bronchiole (TB) and its alveolar ducts (AD), as well as
smallparenchymal vessels. The vessels were placed into three
groups according to their anatomical location in the section
relative to the terminal bronchiole. The three groups are: 1)
adjacent to the terminal bronchiole. 2) not directly adjacent
to, but within 100 sum of the terminal bronchiole, and 3) pe-
ripheral to (further than 100 IA m from) the terminal bronchi-
ole.
phy were put on parlodion-coated one-hole grids and
stained with uranyl acetate and lead citrate for examina-
tion by transmission electron microscopy (JOZEL 100CX
electron microscope). A series of overlapping micro-
graphs of each vessel was taken at 2600X and a mon-
tage of each vessel was constructed from the micro-
graphs. The length of the endothelial cell basement mem-
brane around each vessel and the length of the periphery
of the smooth muscle cell layer were measured from the
montage using a Hewlett-Packard 9830 computer and
model 9864A digitizer. The thickness of the smooth mus-
cle cell layer was calculated as the average distance be-
tween the basement membrane and the periphery of the
smooth muscle cells. In addition, the number of endothe-
lial and smooth muscle cell nuclei were counted and ex-
pressed as the number of nuclei per length of the base-
ment membrane around each vessel. Cells of the vessels
were also examined for the presence of asbestos fibers.
Statistical Analysis
A one-way analysis of variance on the mean labeling indi-
ces, transposed using the arcsine square root transfor-
mation, was used to determine if differences in vascular
and interstitial cell incorporation of 3H-TdR among the
eight time points were significant.21 Fisher's Least Sig-
nificance Difference test was used to determine at which
time points incorporation of 3H-TdR was significantly ele-
vated relative to the sham-exposed animals and to ani-
mals examined zero hours after exposure.22 Fisher's Ex-
act test was used to determine the significance of differ-
ences in labeling of vessels at different locations relative
to the terminal bronchiole, and the Chi-square test was
used to determine whether differences in the size of la-
beled and unlabeled vessels were significant. Morpho-
metric measurements of smooth muscle cell number and




We examined 690 endothelial and 874 smooth muscle
cells in 90 vessels from 21 control animals and found that
no endothelial or smooth muscle cells had incorporated
3H-thymidine at any point in time (24, 48, 72 hours, or 1
month) after sham exposure.
Asbestos-exposed Animals
Endothelial, smooth muscle, and interstitial cells of
small vessels near the first alveolar duct bifurcations (Fig-
ure 1) in the lungs of mice and rats, exhibited dramatic
increases in incorporation of 3H-TdR, 19 to 72 hours after
chrysotile asbestos inhalation. In this distal region of the
lung parenchyma it proved difficult to accurately and con-
sistently establish whether the labeled vessels were arteri-
oles or venules based on wall thickness. However, it ap-
peared that both venules and arterioles exhibited labeled
cells and light microscopy showed unequivocal evidence
of many labeled cells (Figure 2).
Time Course of Labeling
A total of 366 vessels from 72 asbestos-exposed animals
were examined for labeled cells. The percentage of ves-
sels with at least one endothelial or smooth muscle cell
labeled at varying times after exposure is shown in Figure
3. Labeling was greatest (28%) 31 hours after exposure,
decreasing after 72 hours, and remaining low 1 month
after. A similar time course was exhibited by endothelial
cells of the small vessels. These cells had increased lev-
els of 3H-TdR incorporation 19 to 72 hours after exposure
(Figure 4) and the data were statistically increased sig-
nificantly 31 and 48 hours after exposure. Endothelial cells
from an average of 5 vessels per animal were counted
from 6 to 18 animals per time group. Although the varia-
tion among animals is large, there were statistically sig-
nificant increases in labeling 31 and 48 hours after asbes-
tos exposure, compared to sham-exposed controls and
the zero-hour time group, both of which exhibited no label-
ing of endothelial cells. Labeling of smooth muscle cells
followed a timecourse similar to the endothelial cells with
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Figure 2. a: Light micrograph ofa vessel (deliniated by rectangle) adjacent to a terminal bronchiole (TB)from a mouse 48 hours
after chrysotile exposure. The vessel is enlarged in b to show the labeled cells. b: Arrowspoint to the endothelial and smooth muscle
cells that have incorporated3H-thymidine. Labeled interstitial cells (arrowheads) are also seen. c: Transmission electron micrograph
that confirms that the 3H-thymidine-labeled cells deliniated by the rectangle in b are indeed smooth muscle (SMC) and endothelial
cells (EC). d and e: Autoradiographs ofsmallpulmonary vesselsfrom two mice examined 48 hours after exposure to chrysotile asbestos.
Arrowspoint to endothelial cells and arrowheads to smooth muscle cells that have incorporated 3H-thymidine. More than 30% ofthe
smooth muscle cell nuclei in the vessel in panel d are labeled. There are labeled epithelial cells (EP) in the bronchioles. Labeled
interstitial cells (IC) surround the vessel in d anda type II epithelial cell (II) is seen in e.
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Figure 3. The percentage of vessels, ran- 00
domly selectedfrom the bronchiolar-alveo- 0 10 -
lar regions ofmice with at least one endo- w c
thelial or smooth muscle cell labeled at CC
varying times after a brief exposure to L 0
chrysotile asbestos. Maximum labeling was >L
seen 31 to 48 hours after exposure, de- 0
creasing by 72 hours, and remaining low 0 -
8 days and 1 month after exposure. Label-
ing of vessels in sham-exposed controls ex-
amined 24, 48, 72 hours and I month after
exposure was zero.
increases averaging 4.8 ± 2.5% of cells labeled 48 hours
after exposure. The variability in smooth muscle cell label-
ing among animals was sufficiently large to preclude dem-
onstration of statistically significant differences in 3H-thy-
midine incorporation over time. However it is clear that
smooth muscle cells of some vessels showed a dramatic
increase in 3H-TdR incorporation, as high as 30% in some
cases (Figure 2).
Similar to observations in previous studies with asbes-
tos-exposed rats,6 the mice studied here had increased
numbers of interstitial cells labeled with 3H-TdR (Figure
2). Sham-exposed animals never exhibited more than 1 %
labeling at any time point, while between 24 to 72 hours
Figure 4. The timecourse of 3H-thymidine
incorporation by endothelial cells ofsmall
parenchymal vessels in asbestos-exposed
mice. The values represent the means and
standard deviations of the percentage of
labeled cells (labeling index) among ani-
mals at each time point. There was an av-
erage of5 vesselsfrom one or two bifurca-
tions per animal and an average of eight
animals per time point. Labeling of endo-
thelial cells in control animals examined
24, 48, 72 hours, and 1 month after sham
exposure was zero. 3H-thymidine incorpo-
ration 31 and 48 hours after asbestos expo-
sure was significantly different by Fisher's
Least Significant Difference test,2 from the
value of zero incorporation exhibited by
both sham-exposed animals and those ex-























0 hrs 19 hrs 24 hrs 31 hrs 48 hrs 72 hrs 8 days 1 month
TIME AFTER CHRYSOTILE INHALATION
after a mean labeling index of 2.3 ± 0.8% labeled intersti-
tial cells was maintained (Figure 5).
As noted above, asbestos-exposed rats have been
studied to establish the timecourse of 3H-TdR incorpora-
tion by epithelial and interstitial cells of the first alveolar
duct bifurcations.6 We have used these same tissues in a
retrospective fashion and report here that the asbestos-
exposed rats exhibited a similar timecourse of labeling of
the small vessels near first alveolar duct bifurcations, with
9.1% of vessels labeled in 16 animals (4 per time point)
examined 19, 24, 33, and 48 hours after chrysotile inhala-
tion. No labeled endothelial or smooth muscle cells were
found in sham-exposed controls or in rats that had
Oh 19h 24h 31h 48 h 72h 8da Imo
TIME AFTER CHRYSOTILE EXPOSURE
ENDOTHELIAL CELLS
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INTERSTITIAL CELLS
Figure 5. The timecourse of3H-TdR incor-
poration in interstitial cells surrounding
the small parenchymal vessels in asbestos-
exposed mice. Labeling of interstitial cells
in sham-exposed control animals was less
than 1%.
ited significantly higher levels of labeling than those that
were more peripheral.
Size of Labeled Vessels
We found no evidence that the presence of labeled endo-
thelial or smooth muscle cells correlated with vessel size.
The majority of vessels in the bifurcation region were be-
tween 30 and 90 ,um in diameter. The mean diameter of
all vessels measured was 59.3 ± 35.6 (SD) jAm (n = 135).
Oh 19h 24h31h 48 h 72h 8da imo
EC TIME AFTER CHRYSOTILE EXPO
a.
been exposed to carbonyl iron, a nonfibrogenic control
particle.6
Location of Labeled Vessels
Vessels were grouped into three categories according to
their relative location to terminal bronchioles (Methods
and Figure 1). Figure 6 shows the percentage of labeled
vessels from mice between 19 and 72 hours after asbes-
tos exposure. Vessels adjacent to the bronchioles exhib-
Figure 6. The percentage ofvessels with la-
beled endothelial orsmooth muscle cells in
three anatomical locations relative to the
LOCATION OF LABELED VESSELS terminal bronchiole in asbestos-exposed
mice, 19 to 72 hours after chrysotile expo-
sure. Differences in labeling between ves-
sels adjacent and vessels peripheral to the
terminal bronchiole are statistically sig-
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Figure 7. The size distribution of labeled
vessels (solid bars) and total vessels (white
bars) in animals 19 to 72 hours after asbes-
tos exposure. There is no diJference in the
size distribution between labeled and total Th
vessels (Chi-square test). (label
Figure 7 shows that the size distribution of labeled vessels
was not significantly different (Chi-square test) from the
distribution of all the vessels from mice examined 19 to
72 hours after exposure. The reaction appeared to be re-
stricted to vessels larger than 20 ,um. Labeling of capillary
endothelial cells was not increased in the asbestos-ex-
posed animals.
Morphometry
There was no difference in the number of endothelial or
smooth muscle cells nor in the thickness of the smooth
muscle cell layer in any animals examined 72 hours or 8
days after exposure. Endothelial cell number appeared to
be slightly elevated in vessels from mice studied 1 month
after exposure (0.05 ± 0.01 endothelial cells per length of
basement membrane compared to 0.04 ± 0.02 cells in
control animals), but this difference did not reach statisti-
cal significance. However, there were significant differ-
ences in both the thickness of the media and the number
of smooth muscle cells per length of basement mem-
brane 1 month after exposure (Figure 8). Both the number
of smooth muscle cells and the thickness of the smooth
muscle cell layer were nearly doubled in asbestos-ex-
posed mice compared to sham-exposed controls.
We have seen no asbestos fibers in the vessel lumens
or walls, even 1 month after exposure, when fibers com-
monly are observed in interstitial cells and tissues of the
alveolar duct bifurcations.4-5-23-24
Discussion
An increase in 3H-thymidine incorporation by endothelial
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ie number of 3H-thymidine labeled vessels and total
led and unlabeled) vessels grouped according to size.
first alveolar duct bifurcations in the lungs of mice has
been demonstrated 19 to 72 hours after inhalation of
chrysotile asbestos. Both arterioles and venules between
20 and 150,gm in diameter were affected. Labeled nuclei
of capillary endothelial cells rarely were encountered, and
this is consistent with the findings of Chang et al.,5 who
showed that the number and volume of capillary endothe-
lial cells were not significantly altered in rats 48 hours or 1
month after a single exposure to asbestos.
Interestingly, more of the vessels next to terminal bron-
chioles were labeled than those peripheral to the small
airways. This may be because the adjacent vessels are
closer to the asbestos fibers, which have been translo-
cated and retained in interstitial cells and tissues.4 62324
We know that the labeling of alveolar type 11 and interstitial
cells,6 as well as the interstitial changes determined by
morphometry,5 are confined to the first alveolar duct bi-
furcations. Therefore, it is not unreasonable to expect that
the cellular reaction in the vessels would follow a similar
pattern.
To our knowledge, there are no other reports demon-
strating incorporation of 3H-TdR simultaneously by both
endothelial and smooth muscle cells in the small vessels,
other than during wound healing or neoplastic growth
(oral personal communication, November 1988, Dr. J.
Folkman, Department of Surgery, Harvard University Chil-
drens Hospital). However, simultaneous 3H-TdR incorpo-
ration has been demonstrated in larger vessels, in models
of arterial injury2526 and pulmonary hypertension.27 Appar-
ently, a brief asbestos exposure can cause a mitogenic
response in both smooth muscle and endothelial cells of
small pulmonary vessels. This seems particularly signifi-
cant when considering the extremely low replication rate
of these cells in normal adult humans and animals11-14
and that labeling in sham-exposed animals is zero. The
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Figure 8. Ultrastructural morphometry
demonstrated that the thickness of the
smooth muscle cell layer and the number
ofsmooth muscle cells per length of base-
ment membrane were approximately dou-
bled in vessels of asbestos-exposed mice
compared to sham-exposed controls 1
month after exposure. Statistical compari-
sons were made using a two-sided t-test.
responses in the vessels 19 to 72 hours after exposure
are likely to be biologically significant because this time
course coincides with that of bronchiolar and alveolar epi-
thelial and interstitial cell labeling observed at first alveolar
duct bifurcations in asbestos-exposed rats and mice.6'28
These initial changes then progress to focal fibrotic le-
sions.5 The parallel time course of the early proliferative
responses suggests that similar stimuli could be responsi-
ble for 3H-TdR incorporation by the different cell types.
Labeling of interstitial cells in sham-exposed control ani-
mals was less than 1 %, in accordance with control levels
of interstitial cell labeling reported in other studies.62930
Incorporation of 3H-TdR in interstitial cells surrounding the
vessels was no greater than that observed in interstitial
cells surrounding the terminal bronchioles in rats and mice
24 to 48 hours after a brief asbestos exposure.6'28 As we
have seen in other studies,8'28 rats and mice show a sim-
ilar reaction to asbestos inhalation. It is interesting that car-
bonyl iron, which has been found to cause no 3H-TdR
incorporation and no fibrotic lesions 1 month after chryso-
tile exposure in this rodent model,6 also caused no re-
sponse in the vessels.
The thickness of the smooth muscle cell layer and the
number of smooth muscle cells is significantly increased
1 month after exposure. The physiologic significance of
this hyperplastic response of the smooth muscle cell layer
in these animals is not clear. The abnormal growth of
blood vessels often is associated with damage to endo-
thelial cells25 and changes in the basement mem-
brane.31'32 We have observed no morphologic changes
indicating cytotoxicity or the death of endothelial or
smooth muscle cells, nor was there any evidence that as-
bestos inhalation caused an alteration in the basement
membrane. In studies of hypoxia and crotalaria-induced
hypertension, Meyrick and Reid26 27 showed that 3H-TdR
uptake in endothelial cells after cellular injury occurred 7
to 14 days after the exposure. Also, Koo and Gotlieb33
recently showed that peak incorporation of 3H-TdR by
vascular cells occurred 5 to 7 days after mechanical de-
nudation of the endothelium in cultures of aortic tissue.
The proliferative response to injury observed in these
studies occurred days to weeks later than the peak incor-
poration seen here in the asbestos-exposed animals. On
the other hand, Polverini and coworkers' showed peak
labeling of endothelial cells 48 hours after the induction of
delayed hypersensitivity reactions. Interestingly, this coin-
cided with the time of peak monocyte infiltration and the
endothelial response was attributed to the release of un-
identified mitogenic factors.
A mechanism to explain the rapid mitogenic response
of the vascular cells to asbestos is lacking. Although de-
posited asbestos fibers are taken up by the type epithe-
lium and are translocated to the alveolar interstitium,4 6.24
fibers do not appear to be translocated to the vessels. A
lack of fibers and no apparent injury to cells in the vascula-
ture suggest an indirect mechanism of asbestos-induced
proliferative response. The fact that many different cell
types in closely apposed anatomic regions simulta-
neously respond so rapidly after asbestos inhalation sug-
gests that diffusible growth mediators are released, rather
than the occurrence of mechanical or toxic injury, which
appears to cause a more delayed 3H-TdR incorporation
by vascular cells, as discussed above.2627'33
There are many growth factors that have the capacity
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muscle cells in culture35 and induce new blood vessel
growth in angiogenesis assays.36 These same factors
could influence cells in the lung. Possible sources of mito-
genic stimuli are the alveolar and/or interstitial macro-
phages that accumulate in response to asbestos deposi-
tion and complement activation.5'8 The anatomic distribu-
tion of macrophages and the timecourse of macrophage
accumulation correspond to the location and timecourse
of the mitogenic response of cells in the vessels and in
adjacent bifurcations and terminal bronchioles.5'6810 Ac-
tivated macrophages are known to secrete a variety of
factors that can mediate the growth of endothelial,
smooth muscle, and interstitial cells in culture .3537 38 Mac-
rophage-derived growth factors that induce the prolifera-
tion of fibroblasts39-41 and increase 3H-TdR incorporation
by type 11 epithelial cells42 in vitro have been clearly dem-
onstrated. Macrophages and macrophage-conditioned
medium cause endothelial cell proliferation in a variety of
assays,1643 48and can stimulate proliferation of endothe-
lial cells in vitro. Tumor-associated macrophages similarly
have been shown to secrete substances that are angio-
genic and induce endothelial cell proliferation in vitro.49 In
addition, macrophages secrete transforming growth fact-
or-a,5 an angiogenic peptide that is a potent growth fac-
tor for epithelial cells.51 Macrophages also release fibro-
blast growth factors,52 tumor necrosis factor,'5 inter-
leukin-1,5 prostagladin E2,60 and leukotrienes,61 all of
which are angiogenic or mitogenic for endothelial cells
and/or smooth muscle cells. Macrophages also make
transforming growth factor-j3,62 which does not stimulate
endothelial cells in vitro but is active in angiogenesis as-
says.63 Platelet-derived growth factor, a potent mitogen
for smooth muscle cells and fibroblasts,6465 is made by
both macrophages66-69 and endothelial ceHs.70 Thus there
are likely to be at least several cell types involved in a
complex system of paracrine regulation of the rapid re-
sponse observed in the small pulmonary vessels. We
have not observed any accumulation of neutrophils or
platelets at the sites of 3H-TdR incorporation3 5.8 and have
no reason to suspect that these cells are involved in the
response.
Presently there is not enough information to allow an
understanding of which cell types and growth factors are
interacting to cause the vascular response in vivo. The
candidates for the factors that could cause the increase
in 3H-TdR incorporation and hyperplasia obviously are nu-
merous and complex, as discussed above. Because the
asbestos-induced response occurs so rapidly after expo-
sure and in the absence of overt signs of inflammation,
other than macrophage accumulation, we postulate that
these cells release growth factors that at least initiate the
pathobiologic responses of hyperplasia and local fibro-
genesis. This model provides an anatomic basis for
choosing the cell types and time periods for ongoing in
vitro studies designed to characterize the factors involved
and the cells that produce them.
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